REYON Pharmaceutical (co-CEOs Jeong Soon-ok and Yoo Yong-hwan) unveiled its new corporate identity (CI) embodying its commitment to preparing for a second chapter as a leading pharmaceutical company in the bio and chemical market with the corporate philosophy to research the principles of life that it has maintained for 65 years since its establishment. 

The new CI is designed as a future-oriented wordmark, with the open alphabet “R” representing “endless R” that symbolizes endless research to discover the essence of life, the recovery of life and health, and the relationship with the world. 

“[The CI] reflects our commitment contribute to the lives and health of humanity through our second leap as a global bio & chemical pharmaceutical company and our ultimate objective for the next century, based on our belief and mission as a pharmaceutical company studying the principles of life for the past 65 years,” explained an official from the company. 

REYON Pharmaceutical has also reopened its website after a renewal. The upgraded website presenting the CI motif, which is in line with the latest trends, has improved accessibility and convenience.

The company held a new year’s kick-off meeting and the CI declaration ceremony online via groupware in compliance with the government’s physical distancing policy issued in response to the COVID-19 outbreak. During the ceremony, the attendees checked the progress toward BEST till 2023, the vision declared in 2019, and cemented their commitment to the new year’s goals.